Hartmut Derendorf

18.4k total citations · 1 hit paper
353 papers, 13.5k citations indexed

About

Hartmut Derendorf is a scholar working on Pharmacology, Analytical Chemistry and Physiology. According to data from OpenAlex, Hartmut Derendorf has authored 353 papers receiving a total of 13.5k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Pharmacology, 54 papers in Analytical Chemistry and 50 papers in Physiology. Recurrent topics in Hartmut Derendorf's work include Antibiotics Pharmacokinetics and Efficacy (123 papers), Analytical Methods in Pharmaceuticals (54 papers) and Antibiotic Resistance in Bacteria (46 papers). Hartmut Derendorf is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (123 papers), Analytical Methods in Pharmaceuticals (54 papers) and Antibiotic Resistance in Bacteria (46 papers). Hartmut Derendorf collaborates with scholars based in United States, Germany and Austria. Hartmut Derendorf's co-authors include Bernd Meibohm, Stephan Schmidt, Günther Hochhaus, H Möllmann, Susanne U. Mertens‐Talcott, Ursula Theuretzbacher, Veronika Butterweck, Daniel González, Jürgen Barth and Markus Veit and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Microbiology Reviews and Advanced Drug Delivery Reviews.

In The Last Decade

Hartmut Derendorf

351 papers receiving 13.0k citations

Hit Papers

Pharmacokinetics and Bioavailability of Quercetin Glycosi... 2001 2026 2009 2017 2001 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pharmacokinetics and Bioavailability of Quercetin Glycosides in Humans
    2001 500 citations Hartmut Derendorf et al. The Journal of Clinical Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hartmut Derendorf United States 59 4.1k 2.3k 2.0k 1.7k 1.7k 353 13.5k
Rex N. Brogden New Zealand 85 3.5k 0.9× 3.4k 1.5× 2.0k 1.0× 1.8k 1.0× 722 0.4× 239 18.1k
Mohammad Amjad Kamal Saudi Arabia 58 2.3k 0.6× 5.3k 2.4× 2.0k 1.0× 989 0.6× 760 0.4× 598 15.5k
Daan J. Touw Netherlands 48 2.3k 0.6× 1.2k 0.5× 472 0.2× 1.8k 1.0× 771 0.4× 426 9.4k
William J. Jusko United States 64 2.9k 0.7× 4.3k 1.9× 1.8k 0.9× 1.2k 0.7× 473 0.3× 538 18.6k
Ian Phillips United Kingdom 57 1.8k 0.4× 3.8k 1.7× 736 0.4× 2.1k 1.2× 2.4k 1.4× 386 13.7k
Karen L. Goa New Zealand 77 2.4k 0.6× 3.0k 1.3× 1.4k 0.7× 2.0k 1.2× 225 0.1× 282 19.1k
Nicholas H. G. Holford New Zealand 59 3.0k 0.7× 1.5k 0.7× 666 0.3× 1.1k 0.6× 298 0.2× 210 12.9k
Paul M. Tulkens Belgium 66 4.7k 1.1× 6.0k 2.6× 941 0.5× 2.6k 1.5× 3.5k 2.0× 348 16.4k
Kwok‐Pui Fung Hong Kong 65 1.9k 0.5× 7.2k 3.2× 758 0.4× 935 0.5× 462 0.3× 457 16.2k
Andrew J. McLachlan Australia 64 3.6k 0.9× 1.2k 0.5× 1.1k 0.6× 1.6k 0.9× 259 0.1× 450 15.5k

Countries citing papers authored by Hartmut Derendorf

Since Specialization
Citations

This map shows the geographic impact of Hartmut Derendorf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hartmut Derendorf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hartmut Derendorf more than expected).

Fields of papers citing papers by Hartmut Derendorf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hartmut Derendorf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hartmut Derendorf. The network helps show where Hartmut Derendorf may publish in the future.

Co-authorship network of co-authors of Hartmut Derendorf

This figure shows the co-authorship network connecting the top 25 collaborators of Hartmut Derendorf. A scholar is included among the top collaborators of Hartmut Derendorf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hartmut Derendorf. Hartmut Derendorf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanchez, L. Chris, Amanda M. House, Caryn E. Plummer, et al.. (2020). Plasma l ‐indospicine and 3‐nitropropionic acid in ponies fed creeping indigo: Comparison with results from an episode of presumptive creeping indigo toxicosis. Equine Veterinary Journal. 54(1). 145–152. 1 indexed citations
2.
Chandasana, Hardik, et al.. (2018). Bioanalytical method development and validation for determination of fibroblast growth factor peptide and its application to pharmacokinetic studies. European Journal of Pharmaceutics and Biopharmaceutics. 135. 83–93. 2 indexed citations
3.
Sy, Sherwin K. B., et al.. (2018). Mycobacterium tuberculosis Strains H37ra and H37rv have equivalent minimum inhibitory concentrations to most antituberculosis drugs. International Journal of Mycobacteriology. 7(2). 156–156. 65 indexed citations
4.
Deitchman, Amelia N., Ravi Shankar Prasad Singh, Kenneth H. Rand, & Hartmut Derendorf. (2018). Enhanced in vitro activity of tigecycline in the presence of chelating agents. International Journal of Antimicrobial Agents. 51(5). 799–802. 4 indexed citations
5.
Singh, Ravi Shankar Prasad, et al.. (2017). A need to revisit clinical breakpoints of tigecycline: effect of atypical non-linear plasma protein binding. International Journal of Antimicrobial Agents. 49(4). 449–455. 15 indexed citations
6.
Deitchman, Amelia N., et al.. (2016). Utility of Microdialysis in Infectious Disease Drug Development and Dose Optimization. The AAPS Journal. 19(2). 334–342. 12 indexed citations
7.
Sy, Sherwin K. B., Eduardo Asín‐Prieto, Bernd Rosenkranz, et al.. (2015). Effect of reducing the paediatric stavudine dose by half: A physiologically-based pharmacokinetic model. International Journal of Antimicrobial Agents. 45(4). 413–419. 11 indexed citations
8.
Mukker, Jatinder Kaur, Ravi Shankar Prasad Singh, & Hartmut Derendorf. (2014). Determination of Atypical Nonlinear Plasma–Protein-Binding Behavior of Tigecycline Using an In Vitro Microdialysis Technique. Journal of Pharmaceutical Sciences. 103(3). 1013–1019. 27 indexed citations
9.
Singh, Rajendra, et al.. (2013). Population Pharmacokinetics of Methotrexate in Egyptian Children with Lymphoblastic Leukemia. Pharmacology & Pharmacy. 4(2). 139–145. 8 indexed citations
10.
Morey, Timothy E., Scott Wasdo, Brian Quinn, et al.. (2012). Feasibility of a Breath Test for Monitoring Adherence to Vaginal Administration of Antiretroviral Microbicide Gels. The Journal of Clinical Pharmacology. 53(1). 103–111. 19 indexed citations
11.
Ardjomand-Woelkart, Karin, Manfred Kollroser, Christoph Magnes, et al.. (2011). Absolute/Relative Bioavailability and Metabolism of Dodeca-2E,4E,8Z,10E/Z-Tetraenoic Acid Isobutylamides (Tetraenes) after Intravenous and Oral Single Doses to Rats. Planta Medica. 77(16). 1794–1799. 7 indexed citations
12.
Barbour, April, Stephan Schmidt, Kenneth H. Rand, & Hartmut Derendorf. (2009). Ceftobiprole: a novel cephalosporin with activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). International Journal of Antimicrobial Agents. 34(1). 1–7. 49 indexed citations
13.
Derendorf, Hartmut & Eli O. Meltzer. (2008). Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy. 63(10). 1292–1300. 169 indexed citations
14.
Derendorf, Hartmut, et al.. (2008). Pharmacodynamic activity of the lantibiotic MU1140. International Journal of Antimicrobial Agents. 33(1). 70–74. 46 indexed citations
15.
Derendorf, Hartmut. (2007). Pharmacokinetic and Pharmacodynamic Properties of Inhaled Ciclesonide. The Journal of Clinical Pharmacology. 47(6). 782–789. 43 indexed citations
16.
Krishna, Sanjeev, N. Nagaraja, Tim Planche, et al.. (2001). Population Pharmacokinetics of Intramuscular Quinine in Children with Severe Malaria. Antimicrobial Agents and Chemotherapy. 45(6). 1803–1809. 30 indexed citations
17.
Hochhaus, Günther, et al.. (1998). A selective HPLC/RIA for the determination of budesonide. Journal of Pharmaceutical and Biomedical Analysis. 17(8). 1235–1242. 10 indexed citations
18.
Meibohm, Bernd, Günther Hochhaus, Shashank Rohatagi, et al.. (1997). Dependency of Cortisol Suppression on the Administration Time of Inhaled Corticosteroids. The Journal of Clinical Pharmacology. 37(8). 704–710. 30 indexed citations
19.
Hochhaus, Günther, Anna Ratka, Pascal Druzgala, et al.. (1992). Pharmacokinetic Characterization and Tissue Distribution of the New Glucocorticoid Soft Drug Loteprednol Etabonate in Rats and Dogs. Journal of Pharmaceutical Sciences. 81(12). 1210–1215. 30 indexed citations
20.
Rohdewald, Peter, et al.. (1983). Relationship between saliva levels of metamizol metabolites, bioavailability and analgesic efficacy.. PubMed. 33(7). 985–8. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rex N. Brogden Breakdown of academic impact, for papers by Mohammad Amjad Kamal Breakdown of academic impact, for papers by Daan J. Touw Breakdown of academic impact, for papers by William J. Jusko Breakdown of academic impact, for papers by Ian Phillips Breakdown of academic impact, for papers by Karen L. Goa Breakdown of academic impact, for papers by Nicholas H. G. Holford Breakdown of academic impact, for papers by Paul M. Tulkens Breakdown of academic impact, for papers by Kwok‐Pui Fung Breakdown of academic impact, for papers by Andrew J. McLachlan
Rankless by CCL
2026